AI-generated summary
The authors studied 30 dogs with osteoarthritis in a long-term, double-blinded, crossover design comparing platelet-rich plasma injections, photobiomodulation, and their combination. They report that all treatments produced clinically significant improvements, with the combined therapy showing greater and longer-lasting effects at the final follow-up. The study was conducted in dogs, so results may not apply directly to humans.
- Participants
- 30
- Who or what was studied
- Dogs with osteoarthritis (30 dogs; 19 males and 11 females; mean age 9.4 years; mean body weight 26.6 kg)
- Limits stated in the abstract
- The abstract does not describe a control group or sample size justification, and it is an animal study in dogs rather than people.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
Thirty dogs were equally assigned to a platelet-rich plasma group (PRPG), a photobiomodulation group (PBMTG), or a combined therapies group (PRP + PBMTG). Response to treatment was evaluated with weight-bearing distribution and different owner-reported outcome measures. Evaluations were conducted at 0, +8, +15, +30, +60, +90, +120, +150, and +180 days after the initial treatment. After the first 180 days, a crossover was performed, and a second 180-day follow-up was conducted. A second cross-over was performed, with a final 180-day follow-up. Nineteen males and eleven females were included, with a mean age of 9.4 ± 2.7 years and a body weight of 26.6 ± 3.8 kg. Six hips were classified as mild, eighteen as moderate, and six as severe. All treatments were able to produce clinically significant improvements in different evaluation modalities, with varied degrees of magnitude and duration. At the last follow-up, the combination of PRP and PBMT had a greater effect, showing a significant difference compared to the isolated treatments, with a moderate to large effect size. Kaplan-Meier estimators showed that PRP + PBMTG had more extended periods with better results. PRP and PBMT could improve objective outcomes and client-reported outcome measures in dogs with OA. Their combined use leads to greater, longer-lasting, clinically significant improvements.
Abstract reproduced under the CC BY license. Source: PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Crossover study, Osteoarthritis, Photobiomodulation therapy, Effect size. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.